2Castro M, Corm DL, Su WP, et al. Rheumatic manifestations in myelodysplastic syndromes[J] .J Rheumatol, 1991,18(5):721-727.
3Hebbar M, Brouillard M, Wattel E, et al. Association of myelodysplastic syndrome and relapsing polychondritis: further evidence [J]. Leukemia,1995,9(4) :731-733.
4Billstrom R, Johansson H, Johansson B, et al. Immune-mediated complications in patients with myelodysplastic syndromes clinical and cytogenetic features [ J]. Eur J Haematol, 1995,55 ( 1 ) :42-48.
5Enright H, Jacob HS, Vercellotti G, et al. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy [J] . Br J Haemotology, 1995, 91 ( 2 ) : 403-408.
6Enright H, Miller W. Autoimmune phenomena in patients with myelodysplastic syndromes[J] .Leuk Lymphoma, 1997,24(5-6):483-489.
7Hamblin TJ. Immunological abnormalities in myelodysplastic syndromes[J] .Semin Hematol, 1996,33(2) : 150-162.
8Mufti GJ, Figes A, Hamblin TJ, et al. Immunological abnormalities in myelodysolastic syndromes. I. Serum immunoglobulins and autoantibodies[ J]. Br J Haematol, 1986,63( 1 ) : 143-147.
9Okamoto T, Okada M, Mori A, et al. Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients [ J].Int J Haematol, 1997,66(3):345-351.
1Jonasova A,Neuwistava R,Cera KJ,et al.Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow[].British Journal of Haematology.1998
2Biesma DH,van den Tweel JG,Verdonc KLF.Immunosuppressive therapy for hypoplastic myelodysplastic syndrome[].Cancer.1997
